Blood purification could tackle COVID-19?
J Intensive Care
; 9(1): 74, 2021 Dec 11.
Article
in English
| MEDLINE | ID: covidwho-1571936
ABSTRACT
Coronavirus disease 2019 (COVID-19) threatened human lives worldwide since first reported. The current challenge for global intensivists is to establish an effective treatment for severe COVID-19. Blood purification has been applied to the treatment of various critical illnesses. Theoretically, its technique also has an enormous possibility of treating severe COVID-19 in managing inflammatory cytokines and coagulopathy. Recent clinical studies have revealed the positive clinical effect of therapeutic plasma exchange. Other studies have also indicated the considerable potential of other blood purification techniques, such as Cytosorb, AN69 surface-treated membrane, and polymyxin b hemoperfusion. Further research is needed to elucidate the actual effects of these applications.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Language:
English
Journal:
J Intensive Care
Year:
2021
Document Type:
Article
Affiliation country:
S40560-021-00586-0
Similar
MEDLINE
...
LILACS
LIS